19 Recruiting Neuroblastoma Phase 2 Clinical Trials
Active phase 2 studies for neuroblastoma enrolling across the USA. Verify eligibility and contact site coordinators.
All Neuroblastoma studiesPhase 2 Studies for Neuroblastoma
Neuroblastoma Maintenance Therapy Trial
📍 University of Alabama, Children's of Alabama — Birmingham, Alabama
View Study & Checklist ➔Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone Marrow
📍 Riley Hospital for Children — Indianapolis, Indiana
View Study & Checklist ➔Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma
📍 University of Alabama/Children's of Alabama — Birmingham, Alabama
View Study & Checklist ➔Allogeneic Tumor Cell Vaccination With Oral Metronomic Cytoxan in Patients With High-Risk Neuroblastoma
📍 Texas Children's Hospital — Houston, Texas
View Study & Checklist ➔Combination Therapy of Antibody Hu3F8 With Granulocyte- Macrophage Colony Stimulating Factor (GM-CSF) in Patients With Relapsed/Refractory High-Risk Neuroblastoma
📍 Memorial Sloan Kettering Cancer Center — New York, New York
View Study & Checklist ➔NANT 2021-02: Randomized MIBG With Vorinostat/Dinutuximab/Vorinostat + Dinutuximab
📍 Children's Hospital Los Angeles — Los Angeles, California
View Study & Checklist ➔68Ga-DOTATATE Neuroblastoma Imaging Pilot
📍 McGill University Health Center - Children's hospital — Montreal, Quebec
View Study & Checklist ➔Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
📍 Masonic Cancer Center, University of Minnesota — Minneapolis, Minnesota
View Study & Checklist ➔Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
📍 Memorial Sloan Kettering Cancer Center — New York, New York
View Study & Checklist ➔Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
📍 University of Alabama/Children's of Alabama — Birmingham, Alabama
View Study & Checklist ➔NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial
📍 Children's Hospital Los Angeles — Los Angeles, California
View Study & Checklist ➔Haploidentical Donor Cytokine-Induced Memory-Like Natural Killer Cells (CIML-NK) for Relapsed & Refractory Neuroblastoma
📍 Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio
View Study & Checklist ➔A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma
📍 Memorial Sloan Kettering Cancer Center — New York, New York
View Study & Checklist ➔A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma
📍 Memorial Sloan Kettering at Basking Ridge (Consent only) — Basking Ridge, New Jersey
View Study & Checklist ➔Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
📍 Arkansas Children's Hospital — Little Rock, Arkansas
View Study & Checklist ➔Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors
📍 University of Florida — Gainesville, Florida
View Study & Checklist ➔Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
📍 University of Alabama/Children's of Alabama — Birmingham, Alabama
View Study & Checklist ➔Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
📍 University of Alabama/Children's of Alabama — Birmingham, Alabama
View Study & Checklist ➔A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
📍 Children's Hospital of Alabama/UAB — Birmingham, Alabama
View Study & Checklist ➔